• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Emerging drugs for cancer-related pain.

作者信息

Mercadante Sebastiano

出版信息

Support Care Cancer. 2011 Dec;19(12):1887-93. doi: 10.1007/s00520-011-1281-y. Epub 2011 Sep 23.

DOI:10.1007/s00520-011-1281-y
PMID:21938596
Abstract
摘要

相似文献

1
Emerging drugs for cancer-related pain.新型癌症相关疼痛治疗药物
Support Care Cancer. 2011 Dec;19(12):1887-93. doi: 10.1007/s00520-011-1281-y. Epub 2011 Sep 23.
2
Pain relief in terminally ill patients.晚期绝症患者的疼痛缓解
Am Fam Physician. 1989 Dec;40(6):133-40.
3
Drug therapy in cancer pain.癌症疼痛的药物治疗
J Med Assoc Ga. 1991 May;80(5):295-300.
4
Is the WHO analgesic ladder still valid? Twenty-four years of experience.世界卫生组织的镇痛阶梯疗法仍然有效吗？二十四年的经验。
Can Fam Physician. 2010 Jun;56(6):514-7, e202-5.
5
[Cancer pain: therapy according to the pain relief ladder].[癌症疼痛：根据止痛阶梯进行治疗]
MMW Fortschr Med. 2010 May 27;152(21):91-3, 95; quiz 96. doi: 10.1007/BF03366650.
6
Cancer pain: pharmacological management (Part Two).癌症疼痛：药物治疗（第二部分）。
J Med Liban. 1993;41(4):244-8.
7
The scientific basis for analgesic use in dentistry.牙科中使用镇痛药的科学依据。
Anesth Prog. 1986 May-Jun;33(3):123-38.
8
The importance of non-opioid analgesics for cancer pain relief according to the guidelines of the World Health Organization.根据世界卫生组织的指南，非阿片类镇痛药在缓解癌痛方面的重要性。
Int J Clin Pharmacol Res. 1991;11(6):253-60.
9
Opioid and adjuvant analgesics: compared and contrasted.阿片类和辅助镇痛药：比较与对比
Am J Hosp Palliat Care. 2011 Aug;28(5):378-83. doi: 10.1177/1049909111410298. Epub 2011 May 26.
10
[Controlling pain effectively in the elderly. Age is not an analgesic].[有效控制老年人的疼痛。年龄并非镇痛剂]
MMW Fortschr Med. 2006 May 11;148(19):12-3.

引用本文的文献

1
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.与癌症患者中纳洛酮治疗阿片类药物引起的便秘无应答相关的因素：亚组分析。
PLoS One. 2022 Dec 9;17(12):e0278823. doi: 10.1371/journal.pone.0278823. eCollection 2022.
2
Incidence of opioid-induced constipation in Japanese patients with cancer pain: A prospective observational cohort study.癌症疼痛日本患者中阿片类药物引起的便秘发生率：一项前瞻性观察性队列研究。
Cancer Med. 2019 Aug;8(10):4883-4891. doi: 10.1002/cam4.2341. Epub 2019 Jun 24.
3
Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study.

本文引用的文献

1
Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review.阿片类药物治疗癌痛时添加抗癫痫或抗抑郁药物的疗效：系统评价。
Palliat Med. 2011 Jul;25(5):553-9. doi: 10.1177/0269216310378546. Epub 2010 Jul 29.
2
Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain.癌症患者突破性疼痛时鼻内芬太尼喷雾剂的药代动力学
J Opioid Manag. 2010 Jan-Feb;6(1):17-26. doi: 10.5055/jom.2010.0001.
3
Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer.
使用缓释羟考酮/纳洛酮固定组合进行癌症疼痛治疗：一项非干预性研究的结果
Pragmat Obs Res. 2013 Dec 19;5:1-13. doi: 10.2147/POR.S49793. eCollection 2014.
4
Ready conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended release.对于正在使用其他阿片类药物且疼痛得到良好控制的中重度慢性恶性肿瘤相关疼痛患者，可随时转换为使用缓释曲马多。
Clin Drug Investig. 2014 Jul;34(7):501-11. doi: 10.1007/s40261-014-0204-3.
5
Spider peptide Phα1β induces analgesic effect in a model of cancer pain.蜘蛛肽 Phα1β 在癌症疼痛模型中诱导镇痛作用。
Cancer Sci. 2013 Sep;104(9):1226-30. doi: 10.1111/cas.12209. Epub 2013 Jun 25.
鼻腔内芬太尼喷雾与其他阿片类药物治疗癌症爆发性疼痛的疗效比较。
Curr Med Res Opin. 2010 May;26(5):1037-45. doi: 10.1185/03007991003694340.
4
Tapentadol hydrochloride: a centrally acting oral analgesic.盐酸他喷他多：一种中枢作用的口服镇痛药。
Clin Ther. 2009 Dec;31(12):2804-18. doi: 10.1016/j.clinthera.2009.12.003.
5
Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.联合口服缓释羟考酮和纳洛酮治疗阿片类药物诱导的肠道功能障碍：治疗慢性疼痛患者的疗效和安全性数据综述。
Expert Opin Pharmacother. 2010 Feb;11(2):297-310. doi: 10.1517/14656560903483222.
6
Clinical implications of opioid pharmacogenetics.阿片类药物药物遗传学的临床意义。
Clin J Pain. 2010 Jan;26 Suppl 10:S16-20. doi: 10.1097/AJP.0b013e3181c49e11.
7
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study.舌下给予芬太尼治疗癌症患者爆发性疼痛：一项随机 II 期研究结果。
Palliat Med. 2010 Apr;24(3):286-93. doi: 10.1177/0269216309356138. Epub 2009 Dec 16.
8
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.多中心、双盲、随机、安慰剂对照、平行组研究 THC：CBD 提取物和 THC 提取物治疗难治性癌症相关疼痛患者的疗效、安全性和耐受性。
J Pain Symptom Manage. 2010 Feb;39(2):167-79. doi: 10.1016/j.jpainsymman.2009.06.008. Epub 2009 Nov 5.
9
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain.舌下芬太尼口崩片治疗爆发性癌痛的疗效和长期耐受性。
Curr Med Res Opin. 2009 Dec;25(12):2877-85. doi: 10.1185/03007990903368310.
10
A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.鼻内芬太尼喷雾剂与口服枸橼酸芬太尼透粘膜剂治疗癌症突破性疼痛的比较：一项开放标签、随机、交叉试验。
Curr Med Res Opin. 2009 Nov;25(11):2805-15. doi: 10.1185/03007990903336135.